Schedule 13G ownership disclosure

ALX Oncology Holdings, Inc.

Common Stock, par value $0.001 per share · CUSIP: 00166B105

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • TANG CAPITAL MANAGEMENT, LLC

    Shares: 3,158,265.00 · Class: 5.9%

  • KEVIN TANG

    Shares: 3,158,265.00 · Class: 5.9%

  • TANG CAPITAL PARTNERS, LP

    Shares: 1,722,175.00 · Class: 3.2%

  • TANG CAPITAL PARTNERS INTERNATIONAL, LP

    Shares: 1,436,090.00 · Class: 2.7%

  • TANG CAPITAL PARTNERS III, INC

    Shares: 0.00 · Class: 0.0%

  • TANG CAPITAL PARTNERS IV, INC

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-25-007868
Form type
SCHEDULE 13G/A
Filer
ALX ONCOLOGY HOLDINGS INC
CIK
CIK 1810182
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub